Detailed TOC of Global Vaccine Adjuvants Market Report, History and Forecast 2017-2035, Breakdown Data by Manufacturers, Key Regions, Types and Application
1 Vaccine Adjuvants Market Overview
1.1 Vaccine Adjuvants Product Overview
1.2 Vaccine Adjuvants Market Segment by Type
1.2.1 Aluminum Adjuvant
1.2.2 Emulsions Adjuvant
1.2.3 Others
1.3 Global Vaccine Adjuvants Market Size by Type
1.3.1 Global Vaccine Adjuvants Market Size Overview by Type (2017-2035)
1.3.2 Global Vaccine Adjuvants Historic Market Size Review by Type (2017-2026)
1.3.2.1 Global Vaccine Adjuvants Sales Breakdown in Volume by Type (2017-2026)
1.3.2.2 Global Vaccine Adjuvants Sales Breakdown in Value by Type (2017-2026)
1.3.2.3 Global Vaccine Adjuvants Average Selling Price (ASP) by Type (2017-2026)
1.3.3 Global Vaccine Adjuvants Forecasted Market Size by Type (2026-2035)
1.3.3.1 Global Vaccine Adjuvants Sales Breakdown in Volume by Type (2026-2035)
1.3.3.2 Global Vaccine Adjuvants Sales Breakdown in Value by Type (2026-2035)
1.3.3.3 Global Vaccine Adjuvants Average Selling Price (ASP) by Type (2026-2035)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vaccine Adjuvants Sales Breakdown by Type (2017-2026)
1.4.2 Europe Vaccine Adjuvants Sales Breakdown by Type (2017-2026)
1.4.3 Asia-Pacific Vaccine Adjuvants Sales Breakdown by Type (2017-2026)
1.4.4 Latin America Vaccine Adjuvants Sales Breakdown by Type (2017-2026)
1.4.5 Middle East and Africa Vaccine Adjuvants Sales Breakdown by Type (2017-2026)
2 Global Vaccine Adjuvants Market Competition by Company
2.1 Global Top Players by Vaccine Adjuvants Sales (2017-2026)
2.2 Global Top Players by Vaccine Adjuvants Revenue (2017-2026)
2.3 Global Top Players Vaccine Adjuvants Price (2017-2026)
2.4 Global Top Manufacturers Vaccine Adjuvants Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vaccine Adjuvants Market Competitive Situation and Trends
2.5.1 Vaccine Adjuvants Market Concentration Rate (2017-2026)
2.5.2 Global 5 and 10 Largest Manufacturers by Vaccine Adjuvants Sales and Revenue in 2021
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vaccine Adjuvants as of 2021)
2.7 Date of Key Manufacturers Enter into Vaccine Adjuvants Market
2.8 Key Manufacturers Vaccine Adjuvants Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vaccine Adjuvants Status and Outlook by Region
3.1 Global Vaccine Adjuvants Market Size and CAGR by Region: 2017 VS 2021 VS 2035
3.2 Global Vaccine Adjuvants Historic Market Size by Region
3.2.1 Global Vaccine Adjuvants Sales in Volume by Region (2017-2026)
3.2.2 Global Vaccine Adjuvants Sales in Value by Region (2017-2026)
3.2.3 Global Vaccine Adjuvants Sales (Volume & Value) Price and Gross Margin (2017-2026)
3.3 Global Vaccine Adjuvants Forecasted Market Size by Region
3.3.1 Global Vaccine Adjuvants Sales in Volume by Region (2026-2035)
3.3.2 Global Vaccine Adjuvants Sales in Value by Region (2026-2035)
3.3.3 Global Vaccine Adjuvants Sales (Volume & Value), Price and Gross Margin (2026-2035)
4 Global Vaccine Adjuvants by Application
4.1 Vaccine Adjuvants Market Segment by Application
4.1.1 Human Vaccine
4.1.2 Veterinary Vaccine
4.2 Global Vaccine Adjuvants Market Size by Application
4.2.1 Global Vaccine Adjuvants Market Size Overview by Application (2017-2035)
4.2.2 Global Vaccine Adjuvants Historic Market Size Review by Application (2017-2026)
4.2.2.1 Global Vaccine Adjuvants Sales Breakdown in Volume, by Application (2017-2026)
4.2.2.2 Global Vaccine Adjuvants Sales Breakdown in Value, by Application (2017-2026)
4.2.2.3 Global Vaccine Adjuvants Average Selling Price (ASP) by Application (2017-2026)
4.2.3 Global Vaccine Adjuvants Forecasted Market Size by Application (2026-2035)
4.2.3.1 Global Vaccine Adjuvants Sales Breakdown in Volume, by Application (2026-2035)
4.2.3.2 Global Vaccine Adjuvants Sales Breakdown in Value, by Application (2026-2035)
4.2.3.3 Global Vaccine Adjuvants Average Selling Price (ASP) by Application (2026-2035)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vaccine Adjuvants Sales Breakdown by Application (2017-2026)
4.3.2 Europe Vaccine Adjuvants Sales Breakdown by Application (2017-2026)
4.3.3 Asia-Pacific Vaccine Adjuvants Sales Breakdown by Application (2017-2026)
4.3.4 Latin America Vaccine Adjuvants Sales Breakdown by Application (2017-2026)
4.3.5 Middle East and Africa Vaccine Adjuvants Sales Breakdown by Application (2017-2026)
5 North America Vaccine Adjuvants by Country
5.1 North America Vaccine Adjuvants Historic Market Size by Country
5.1.1 North America Vaccine Adjuvants Sales in Volume by Country (2017-2026)
5.1.2 North America Vaccine Adjuvants Sales in Value by Country (2017-2026)
5.2 North America Vaccine Adjuvants Forecasted Market Size by Country
5.2.1 North America Vaccine Adjuvants Sales in Volume by Country (2026-2035)
5.2.2 North America Vaccine Adjuvants Sales in Value by Country (2026-2035)
6 Europe Vaccine Adjuvants by Country
6.1 Europe Vaccine Adjuvants Historic Market Size by Country
6.1.1 Europe Vaccine Adjuvants Sales in Volume by Country (2017-2026)
6.1.2 Europe Vaccine Adjuvants Sales in Value by Country (2017-2026)
6.2 Europe Vaccine Adjuvants Forecasted Market Size by Country
6.2.1 Europe Vaccine Adjuvants Sales in Volume by Country (2026-2035)
6.2.2 Europe Vaccine Adjuvants Sales in Value by Country (2026-2035)
7 Asia-Pacific Vaccine Adjuvants by Region
7.1 Asia-Pacific Vaccine Adjuvants Historic Market Size by Region
7.1.1 Asia-Pacific Vaccine Adjuvants Sales in Volume by Region (2017-2026)
7.1.2 Asia-Pacific Vaccine Adjuvants Sales in Value by Region (2017-2026)
7.2 Asia-Pacific Vaccine Adjuvants Forecasted Market Size by Region
7.2.1 Asia-Pacific Vaccine Adjuvants Sales in Volume by Region (2026-2035)
7.2.2 Asia-Pacific Vaccine Adjuvants Sales in Value by Region (2026-2035)
8 Latin America Vaccine Adjuvants by Country
8.1 Latin America Vaccine Adjuvants Historic Market Size by Country
8.1.1 Latin America Vaccine Adjuvants Sales in Volume by Country (2017-2026)
8.1.2 Latin America Vaccine Adjuvants Sales in Value by Country (2017-2026)
8.2 Latin America Vaccine Adjuvants Forecasted Market Size by Country
8.2.1 Latin America Vaccine Adjuvants Sales in Volume by Country (2026-2035)
8.2.2 Latin America Vaccine Adjuvants Sales in Value by Country (2026-2035)
9 Middle East and Africa Vaccine Adjuvants by Country
9.1 Middle East and Africa Vaccine Adjuvants Historic Market Size by Country
9.1.1 Middle East and Africa Vaccine Adjuvants Sales in Volume by Country (2017-2026)
9.1.2 Middle East and Africa Vaccine Adjuvants Sales in Value by Country (2017-2026)
9.2 Middle East and Africa Vaccine Adjuvants Forecasted Market Size by Country
9.2.1 Middle East and Africa Vaccine Adjuvants Sales in Volume by Country (2026-2035)
9.2.2 Middle East and Africa Vaccine Adjuvants Sales in Value by Country (2026-2035)
10 Company Profiles and Key Figures in Vaccine Adjuvants Business
10.1 GSK
10.1.1 GSK Corporation Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2026)
10.1.4 GSK Vaccine Adjuvants Products Offered
10.1.5 GSK Recent Development
10.2 CSL Limited
10.2.1 CSL Limited Corporation Information
10.2.2 CSL Limited Introduction and Business Overview
10.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2026)
10.2.4 CSL Limited Vaccine Adjuvants Products Offered
10.2.5 CSL Limited Recent Development
10.3 Croda
10.3.1 Croda Corporation Information
10.3.2 Croda Introduction and Business Overview
10.3.3 Croda Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2026)
10.3.4 Croda Vaccine Adjuvants Products Offered
10.3.5 Croda Recent Development
10.4 SEPPIC
10.4.1 SEPPIC Corporation Information
10.4.2 SEPPIC Introduction and Business Overview
10.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2026)
10.4.4 SEPPIC Vaccine Adjuvants Products Offered
10.4.5 SEPPIC Recent Development
10.5 Novavax
10.5.1 Novavax Corporation Information
10.5.2 Novavax Introduction and Business Overview
10.5.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2026)
10.5.4 Novavax Vaccine Adjuvants Products Offered
10.5.5 Novavax Recent Development
10.6 SPI Pharma
10.6.1 SPI Pharma Corporation Information
10.6.2 SPI Pharma Introduction and Business Overview
10.6.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2026)
10.6.4 SPI Pharma Vaccine Adjuvants Products Offered
10.6.5 SPI Pharma Recent Development
10.7 Phibro
10.7.1 Phibro Corporation Information
10.7.2 Phibro Introduction and Business Overview
10.7.3 Phibro Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2026)
10.7.4 Phibro Vaccine Adjuvants Products Offered
10.7.5 Phibro Recent Development
10.8 SDA BIO
10.8.1 SDA BIO Corporation Information
10.8.2 SDA BIO Introduction and Business Overview
10.8.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2026)
10.8.4 SDA BIO Vaccine Adjuvants Products Offered
10.8.5 SDA BIO Recent Development
10.9 Invivogen
10.9.1 Invivogen Corporation Information
10.9.2 Invivogen Introduction and Business Overview
10.9.3 Invivogen Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2026)
10.9.4 Invivogen Vaccine Adjuvants Products Offered
10.9.5 Invivogen Recent Development
10.10 Tj Kaiwei
10.10.1 Tj Kaiwei Corporation Information
10.10.2 Tj Kaiwei Introduction and Business Overview
10.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2026)
10.10.4 Tj Kaiwei Vaccine Adjuvants Products Offered
10.10.5 Tj Kaiwei Recent Development
10.11 OZ Biosciences
10.11.1 OZ Biosciences Corporation Information
10.11.2 OZ Biosciences Introduction and Business Overview
10.11.3 OZ Biosciences Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2026)
10.11.4 OZ Biosciences Vaccine Adjuvants Products Offered
10.11.5 OZ Biosciences Recent Development
10.12 Brenntag Biosector
10.12.1 Brenntag Biosector Corporation Information
10.12.2 Brenntag Biosector Introduction and Business Overview
10.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2026)
10.12.4 Brenntag Biosector Vaccine Adjuvants Products Offered
10.12.5 Brenntag Biosector Recent Development
10.13 MVP Laboratories
10.13.1 MVP Laboratories Corporation Information
10.13.2 MVP Laboratories Introduction and Business Overview
10.13.3 MVP Laboratories Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2026)
10.13.4 MVP Laboratories Vaccine Adjuvants Products Offered
10.13.5 MVP Laboratories Recent Development
10.14 Zhuoyue
10.14.1 Zhuoyue Corporation Information
10.14.2 Zhuoyue Introduction and Business Overview
10.14.3 Zhuoyue Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2026)
10.14.4 Zhuoyue Vaccine Adjuvants Products Offered
10.14.5 Zhuoyue Recent Development
10.15 Aphios
10.15.1 Aphios Corporation Information
10.15.2 Aphios Introduction and Business Overview
10.15.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2017-2026)
10.15.4 Aphios Vaccine Adjuvants Products Offered
10.15.5 Aphios Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vaccine Adjuvants Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vaccine Adjuvants Industrial Chain Analysis
11.4 Vaccine Adjuvants Market Dynamics
11.4.1 Vaccine Adjuvants Industry Trends
11.4.2 Vaccine Adjuvants Market Drivers
11.4.3 Vaccine Adjuvants Market Challenges
11.4.4 Vaccine Adjuvants Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vaccine Adjuvants Distributors
12.3 Vaccine Adjuvants Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
